# Warp Sciences

> US chemistry research services combining chemists, AI and robotics for biotech and pharma.

## Why it is interesting

Warp is building laboratory infrastructure for customer-owned drug programs rather than its own proprietary drug pipeline.

## Profile

- **Latest funding:** Series A — $215M (October 22, 2026)
- **Latest known valuation:** $865M post-money, reported by Bloomberg citing the company (October 22, 2026)
- **Total disclosed equity funding:** $215M
- **Stage:** series-a
- **Status:** private
- **Industries:** ai-ml, biotech-life-sciences
- **Coverage:** full
- **Last updated:** 2026-10-26
- **Latest funding investors:** Lightspeed Venture Partners, Premji Invest, Mayfield, IVP, Lux Capital, Conviction, Menlo Ventures, 01 Advisors, Standard, Lowercarbon Capital, Gigascale Capital, Angular Ventures, Scribble Ventures, Uncork Capital, Innovation Endeavors, Matter VP, Zero Shot Fund, SignalFire, Moxxie Ventures

## Funding history

- Series A · $215M · October 22, 2026
  Source: https://www.financialcontent.com/article/bizwire-2026-10-22-warp-sciences-emerges-from-stealth-with-215-million-to-build-us-chemistry-services-for-drug-research

## Investors in our directory

- https://venturecapitaltracker.com/fund/lightspeed-venture-partners-nyc
- https://venturecapitaltracker.com/fund/premji-invest
- https://venturecapitaltracker.com/fund/ivp
- https://venturecapitaltracker.com/fund/lux-capital
- https://venturecapitaltracker.com/fund/menlo-ventures

## Related articles

- https://venturecapitaltracker.com/warp-sciences-215m-series-a-robotic-chemistry

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** October 26, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/warp-sciences